Skip to content

Success rate in the treatment of congenital nasolacrimal duct obstruction

Comparing the modified surgical interventions with Probing, Turbinate fracture and Crowforded in treatment of congenital obstruction of nasolacrimal duct: a Randomized controlled clinical trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20220120053771N1
Enrollment
164
Registered
2022-02-08
Start date
2022-03-21
Completion date
Unknown
Last updated
2022-03-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Congenital obstruction of the nasolacrimal duct. Neonatal obstruction of nasolacrimal duct

Interventions

Intervention 1: Intervention group: Nasolacrimal duct probing surgery with rupture of the lower nasal turbine. Intervention 2: Intervention group: Nasolacrimal duct probing surgery with Crawford impla

Sponsors

Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 5 Years

Inclusion criteria

Inclusion criteria: pure type of congenital nasolacrimal duct obstruction, Age under 5 years, negative fluorosin test without underlying disease or other syndromic disorder, without previous history of nasolacrimal duct intervention or manipulation.

Exclusion criteria

Exclusion criteria: Patient / parent dissatisfaction with the study, uncontrollable infection, underlying disease or limitation of anesthesia, concomitant tumors or bleeding disorders, concomitant disorders of facial ossification, cleft palate (even (Secretly), developmental disorders or defects, problems related to the pituitary gland or Ratke sinus and other abnormalities of the midline of the face.

Design outcomes

Primary

MeasureTime frame
Comparison of success rate in modified surgical intervention methods with probing method with turbine fracture and Crawford implantation in the treatment of congenital nasolacrimal duct obstruction. Timepoint: patients will be examined for the success of the intervention as well as the complications of the interventionm, a day after the intervention,. At 3 months and 6 months after the surgery, patients will be re-evaluated for the visual system and fluorocin test will be performed, and the results of follow-up and examination at times 0, 3 and 6 (months) will be evaluated and compared. Method of measurement: At each follow-up, patients will undergo a complete evaluation of the visual system and perform a fluorescein test.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSahel Soltani Shahgoli

Tehran University of Medical Sciences

sahelsoltan93@gmail.com+98 21 5540 0003

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026